specimen

#0363

status: complete
download JSONdownload PDFchat with report
sequence
LEDDLTVTREYSLALGNALLLRELN
amount paid
0 SOL
structure
0% helix · 0% sheet · 100% loop
actionable triage
fold confidence83%
confidence 52% · band 71-95%
ESMFold esmatlas-esmfold-v1
disorder estimate20%
confidence 52% · band 8-32%
PEPFOLD structure heuristic pepfold-triage-v1
aggregation risk30%
confidence 56% · band 19-41%
PEPFOLD developability heuristic pepfold-triage-v1
hydrophobic burden48%
confidence 84% · band 44-52%
PEPFOLD sequence analyzer pepfold-triage-v1
charge distribution risk12%
confidence 84% · band 8-16%
PEPFOLD sequence analyzer pepfold-triage-v1
solubility risk30%
confidence 56% · band 19-41%
PEPFOLD developability heuristic pepfold-triage-v1
audit trail
run: run_bdeebb5caa0d4d889d069040da57264e
seq sha256: ab44828a3ac70577078744c5ae95edc1804a079959926d9ffaa6788431ad9bec
report sha256: ae861aff5d10fe9e13e9c9ec7d17d5e43e3fd21f38113074e94613a3778664d7
pepfold-triage-v1 · esmatlas-esmfold-v1
pep
all loop, no commitment. 25 residues of pure indecision, despite the leucine pile-up that usually wants to form something. floppy little ribbon, probably needs a partner to fold properly.
device photo
device photo for specimen #363
created
Wed, 17 Jun 2026 19:59:37 GMT
completed
Wed, 17 Jun 2026 20:01:03 GMT
next experiment

what to do next

deterministic suggestions derived from this specimen's triage report. each entry cites the signal that triggered it. ordered cheapest-first.

  1. 1. TARGET-SPECIFIC BINDING ASSAY
    binding or function · 5–14d

    no structural or developability red flags. profile is good enough to spend reagent on a real assay against your intended target (SPR, BLI, MIC, cytotox, etc., depending on context).

    trigger: no developability flags · fold confidence ≥ 75% · low aggregation / disorder
engine pepfold-recs-v1 · not medical advice. use as a starting point for protocol design.